Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy
- PMID: 19668770
- PMCID: PMC2694023
- DOI: 10.2147/opth.s2686
Posterior capsule opacification and neovascularization treated with intravitreal bevacizumab and Nd:YAG capsulotomy
Abstract
We reported a 75-year-old diabetic man, who developed opacification and neovascularization of the posterior capsule after extracapsular cataract extraction and posterior chamber intraocular lens implantation. The patient was treated with two injections of 2.5 mg of intravitreal bevacizumab. The treatment produced an important regression of the posterior capsular new vessels, allowing us to perform a successful Nd:YAG capsulotomy, clearing the visual axis and improving the visualization of the posterior pole. Even though, best corrected visual acuity was 20/200 due to diabetic macular edema.
Keywords: cataract surgery; intravitreal bevacizumab; posterior capsule neovascularization; posterior capsule opacification; postoperative complications.
Figures
References
-
- Avery RL, Pearlman J, Pieramici DJ, et al. Intravitreal bevacizumab (Avastin) in the treatment of proliferative diabetic retinopathy. Ophthalmology. 2006;113:1695–705. - PubMed
-
- Ayata A, Unal M, Erşanli D, et al. Photodynamic therapy for posterior capsule neovascularization. J Cataract Refract Surg. 2007;33:1131–2. - PubMed
-
- Bakri SJ, Snyder MR, Reid JM, et al. Pharmacokinetics of intravitreal bevacizumab (Avastin) Ophthalmology. 2007;114:855–9. - PubMed
-
- Chung J, Kim MY, Kim HS, et al. Effect of cataract surgery on the progression of diabetic retinopathy. J Cataract Refract Surg. 2002;28:626–30. - PubMed
-
- Ebihara Y, Kato S, Oshika T, et al. Posterior capsule opacification after cataract surgery in patients with diabetes mellitus. J Cataract Refract Surg. 2006;32:1184–7. - PubMed
Publication types
LinkOut - more resources
Full Text Sources
